BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12098934)

  • 1. The role of dendritic cells in neurodegenerative diseases.
    Iribarren P; Cui YH; Le Y; Wang JM
    Arch Immunol Ther Exp (Warsz); 2002; 50(3):187-96. PubMed ID: 12098934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-immune connection: immuno-regulatory properties of CNS-resident cells.
    Becher B; Prat A; Antel JP
    Glia; 2000 Feb; 29(4):293-304. PubMed ID: 10652440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases.
    Huang Y; Erdmann N; Peng H; Zhao Y; Zheng J
    Cell Mol Immunol; 2005 Apr; 2(2):113-22. PubMed ID: 16191417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology meets neuroscience--opportunities for immune intervention in neurodegenerative diseases.
    Lynch MA; Mills KH
    Brain Behav Immun; 2012 Jan; 26(1):1-10. PubMed ID: 21664452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L
    Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease.
    Raivich G; Banati R
    Brain Res Brain Res Rev; 2004 Nov; 46(3):261-81. PubMed ID: 15571769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
    Miller SD; McMahon EJ; Schreiner B; Bailey SL
    Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases.
    Pedemonte E; Mancardi G; Giunti D; Corcione A; Benvenuto F; Pistoia V; Uccelli A
    Pharmacol Ther; 2006 Sep; 111(3):555-66. PubMed ID: 16442633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II-associated invariant chain (Ii) modulates dendritic cells-derived microvesicles (DCMV)-mediated activation of microglia.
    Teo BH; Wong SH
    Biochem Biophys Res Commun; 2010 Oct; 400(4):673-8. PubMed ID: 20816669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia, macrophages and the blood-brain barrier.
    Graeber MB
    Clin Neuropathol; 1993; 12(5):296-7. PubMed ID: 8222403
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid dendritic cells infiltrate the brain parenchyma and target the cervical lymph nodes under neuroinflammatory conditions.
    Hatterer E; Touret M; Belin MF; Honnorat J; Nataf S
    PLoS One; 2008 Oct; 3(10):e3321. PubMed ID: 18830405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL; Wiendl H
    Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Espejo C; Martínez-Cáceres EM
    Ann N Y Acad Sci; 2005 Jun; 1051():88-96. PubMed ID: 16126947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells.
    Serafini B; Rosicarelli B; Magliozzi R; Stigliano E; Capello E; Mancardi GL; Aloisi F
    J Neuropathol Exp Neurol; 2006 Feb; 65(2):124-41. PubMed ID: 16462204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is damage in central nervous system due to inflammation?
    Chavarria A; Alcocer-Varela J
    Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA; Millward JM; Owens T
    J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS dendritic cells: critical participants in CNS inflammation?
    McMahon EJ; Bailey SL; Miller SD
    Neurochem Int; 2006 Jul; 49(2):195-203. PubMed ID: 16730862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
    Ponomarev ED; Shriver LP; Maresz K; Dittel BN
    J Neurosci Res; 2005 Aug; 81(3):374-89. PubMed ID: 15959904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.